Evidence map›Paper›PMID 39605674›Full record

ArticlebioRxiv : the preprint server for biology2024

Targeted DNA ADP-ribosylation triggers templated repair in bacteria and base mutagenesis in eukaryotes.

Constantinos Patinios, Darshana Gupta, Harris V Bassett, Scott P Collins, Charlotte Kamm, Anuja Kibe, Yanyan Wang, Chengsong Zhao, Katie Vollen, Christophe Toussaint and 12 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors.

Constantinos PatiniosHelmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), 97072 Würzburg, Germany.ORCID 0000-0002-9306-4593
Darshana GuptaHelmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), 97072 Würzburg, Germany.
Harris V BassettHelmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), 97072 Würzburg, Germany.
Scott P CollinsDepartment of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, NC 27695, USA.
Charlotte KammHelmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), 97072 Würzburg, Germany.
Anuja KibeHelmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), 97072 Würzburg, Germany.
Yanyan WangHelmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), 97072 Würzburg, Germany.
Chengsong ZhaoDepartment of Plant and Microbial Biology, North Carolina State University, Ralegh, NC 27695, USA.
Katie VollenDepartment of Plant and Microbial Biology, North Carolina State University, Ralegh, NC 27695, USA.
Christophe ToussaintHelmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), 97072 Würzburg, Germany.
Kathryn M PolkoffDepartment of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, NC 27695, USA.
Thuan NguyenDepartment of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, NC 27695, USA.
Irene CalvinHelmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), 97072 Würzburg, Germany.
Angela MigurHelmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), 97072 Würzburg, Germany.
Ibrahim S Al'AbriDepartment of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, NC 27695, USA.
Tatjana AchmedovHelmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), 97072 Würzburg, Germany.
Alessandro Del ReHelmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), 97072 Würzburg, Germany.
Antoine-Emmanuel SalibaHelmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), 97072 Würzburg, Germany.
Nathan CrookDepartment of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, NC 27695, USA.
Anna N StepanovaDepartment of Plant and Microbial Biology, North Carolina State University, Ralegh, NC 27695, USA.ORCID 0000-0003-1018-4758
Jose M AlonsoDepartment of Plant and Microbial Biology, North Carolina State University, Ralegh, NC 27695, USA.
Chase L BeiselHelmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Centre for Infection Research (HZI), 97072 Würzburg, Germany.ORCID 0000-0003-0650-9943

Funding

Understanding and exploiting the functional diversity of CRISPR-Cas immune systemsR35GM119561 · NIGMS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI BEISEL, CHASE LAWRENCE · 2016 to 2020
$1.9M
NIGMS NIH HHS R35 GM119561
6 · The paper itself

Abstract

Base editors create precise genomic edits by directing nucleobase deamination or removal without inducing double-stranded DNA breaks. However, a vast chemical space of other DNA modifications remains to be explored for genome editing. Here, we harness the bacterial anti-phage toxin DarT2 to append ADP-ribosyl moieties to DNA, unlocking distinct editing outcomes in bacteria versus eukaryotes. Fusing an attenuated DarT2 to a Cas9 nickase, we program site-specific ADP-ribosylation of thymines within a target DNA sequence. In tested bacteria, targeting drives efficient homologous recombination in tested bacteria, offering flexible and scar-free genome editing without base replacement nor counterselection. In tested eukaryotes including yeast, plants and human cells, targeting drives substitution of the modified thymine to adenine or a mixture of adenine and cytosine with limited insertions or deletions, offering edits inaccessible to current base editors. Altogether, our approach, called append editing, leverages the addition of a chemical moiety to DNA to expand current modalities for precision gene editing.

Identifiers

PMID39605674
PMCPMC11601458

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.